LuX: Xaluritamig in Participants With Metastatic Castrate Resistant Prostate Cancer and Suboptimal Response to Lutetium 177 Vipivotide Tetraxetan
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Xaluritamig
Related studies linked through entity extraction aliases.
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1